Canada home to the first clinical study for a Zika vaccine

(Université Laval) Université Laval's Infectious Disease Research Centre (IDRC) and Centre de recherche du CHU de Québec-Université Laval (CHU) are proud to announce that the first clinical study for a Zika vaccine in Canada is set to begin in Quebec City.

Comments
%d bloggers like this: